PTPRC and neoplasm: Flow cytometric analysis revealed that, as expected, the immune cell subsets most frequently interacting with tumor cells (as measured by tEV uptake) were MHC-II+ Mac (21.3% of total CD45+ CD63-GFP+ cells), followed by B cells (20.6%) and Neu (13%) (Fig 4C), similarly to what we observed before (Fig 2B).